@ARTICLE{
author={Kim Tae Won,Elme Anneli,Park Joon Oh,Udrea Anghel Adrian,Kim Sun Young,Ahn Joong Bae,Valencia Ricardo Villalobos,Krishnan Srinivasan,Manojlovic Nebojsa S,Guan Xuesong,Lofton-Day Catherine,Jung A Scott,Vrdoljak Eduard},
year={2018},
title={Final Analysis of Outcomes and RAS/BRAF Status in a Randomized Phase 3 Study of Panitumumab and Best Supportive Care in Chemorefractory Wild Type KRAS Metastatic Colorectal Cancer},
journal={CLINICAL COLORECTAL CANCER},
volume={17},
number={3},
pages={206-214},
document_type={Article},
} 

@ARTICLE{
author={Kim Tae Won,...,Kusic Zvonko,...,Manojlovic Nebojsa S,...,(broj koautora 16)},
year={2016},
title={Final results from a phase III trial evaluating panitumumab (pmab) plus best supportive care (BSC) vs BSC in chemorefractory wild-type (WT) KRAS exon 2 and WT RAS metastatic colorectal cancer (mCRC).},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={34},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Kim Tae Won,...,Manojlovic Nebojsa S,...,(broj koautora 16)},
year={2016},
title={A phase 3 trial evaluating panitumumab plus best supportive care vs best supportive care in chemorefractory wild-type KRAS or RAS metastatic colorectal cancer},
journal={BRITISH JOURNAL OF CANCER},
volume={115},
number={10},
pages={1206-1214},
document_type={Article},
} 

@ARTICLE{
author={Kim Tae Won,...,(broj koautora 16)},
year={2016},
title={An open label, randomized phase III trial evaluating the treatment (tx) effects of panitumumab (pmab) plus best supportive care (BSC) versus BSC in chemorefractory wild-type (WT) KRAS exon 2 metastatic colorectal cancer (mCRC) and in WT RAS mCRC.},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={34},
number={4},
pages={-},
document_type={Meeting Abstract},
}